What RightHill Ventures does

RightHill Ventures is a Providence, Rhode Island-based seed-stage venture capital firm founded in 2022 by the Slater Technology Fund to provide capital and operational support to early-stage technology companies commercializing university research. The firm concentrates on spinouts from Brown University, the University of Rhode Island, and other higher education institutions, with a portfolio spanning biotechnology (MindImmune Therapeutics, Alcinous Pharmaceuticals, Octagon Therapeutics), medical devices (Lenoss Medical), advanced materials (Adept Materials), and broader technology sectors (VoltServer, RxVantage, HappyNest).

The firm operates through a community-led go-to-market model, sourcing deals directly from university labs and alumni networks and packaging investments via special-purpose vehicles (SPVs) and syndicates of accredited investors, drawing on partners including the Slater Technology Fund, Brown Angel Group, RI-Bio, Brown Biomedical Innovation, and the Brown Nelson Center for Entrepreneurship. Thorne Sparkman serves as Managing Director of both RightHill Ventures and Slater Technology Fund. Marketing and LP acquisition run primarily through the firm website (righthill.vc) and university events such as the Innovation@Brown Showcase.

RightHill's revenue model is standard for an early-stage venture firm: capital deployment via direct equity into portfolio companies (e.g., a $1.5M commitment into MindImmune's $12.4M Series A in 2022, participation in MindImmune's $10.2M Series A extension in 2025, and participation in Lenoss Medical's $6M growth bridge in 2026), with returns expected through exits, IPOs, or follow-on financing. The firm maintains a headcount of 1–10 and does not publicly disclose fund size, management fees, carried interest, or LP composition.

Name

RightHill Ventures

Legal name

RightHill Ventures

Website

https://righthill.vc

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

RightHill Ventures is a Providence-based seed-stage venture capital firm founded in 2022 by the Slater Technology Fund that provides capital and startup support to early-stage technology companies commercializing research from Brown University and the University of Rhode Island through syndicated SPVs.

Ownership category

akta.pro rank

Product category

Seed-Stage Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Investment Banking and Securities Intermediation (523150)

SIC

Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Seed-stage venture capital
• University technology ventures
• Investment syndicate funding
• Early-stage equity investing
• Startup capital funding

Headquarters

HQ city

Providence

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Investment Returns: RightHill Ventures generates returns through equity investments in early-stage university technology companies. As a venture capital firm, they provide seed-stage capital and support to portfolio companies, with returns realized through exits, IPOs, or follow-on funding rounds.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

RightHill Ventures provides seed-stage venture capital and startup support to early-stage technology companies that are commercializing research from university ecosystems, with a primary focus on Brown University and the University of Rhode Island spinouts. The firm structures investment syndicates and special-purpose vehicles (SPVs) that pool accredited investors from university communities to co-invest alongside the Slater Technology Fund, enabling larger seed-stage commitments than its own capital alone. Its current portfolio spans biotechnology, medical devices, advanced materials, and broader technology companies commercializing university-derived intellectual property.

Product overview

RightHill Ventures operates as a single unified venture capital offering focused on providing seed-stage capital and startup support to early-stage technology companies commercializing university research. The firm works in partnership with Brown University, the University of Rhode Island, and other higher education institutions to identify innovators and fund ventures. RightHill Ventures maintains a portfolio of six technology companies spanning biotechnology (MindImmune), medical devices (Lenoss Medical), advanced materials (Adept Materials), and other technology sectors (VoltServer, RxVantage, HappyNest). The firm leverages a network of experienced entrepreneurs, technologists, and accredited investors to fund early milestones through investment syndicates.

Differentiator

Problem solved

Functional benefit

Products and services

• Seed-stage venture capital funding

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Brown UniversitycoreStrategic or Co-development PartnerBrown University is a key university partner for RightHill Ventures. RightHill works in partnership with Brown to identify innovators and entrepreneurs commercializing university research. Brown technology innovations are featured in the RightHill ecosystem.
• University of Rhode IslandcoreStrategic or Co-development PartnerUniversity of Rhode Island is a key university partner. RightHill works in partnership with URI to identify innovators and opportunities emerging from university research. MindImmune Therapeutics is based at URI.
• RI-BiominorStrategic or Co-development PartnerRI-Bio is a partner in the RightHill ecosystem, supporting the life sciences and biotechnology startup community in Rhode Island.
• Brown Biomedical InnovationminorStrategic or Co-development PartnerBrown Biomedical Innovation (BBII) is a partner providing biomedical research and innovation connections within the Brown University ecosystem.
• Brown Nelson Center for EntrepreneurshipminorStrategic or Co-development PartnerThe Nelson Center for Entrepreneurship at Brown University is part of the RightHill ecosystem, supporting entrepreneurship and startup development.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Slater Technology Fund: Rhode Island's oldest and most active seed-stage investment fund and RightHill's founding sponsor. Invests in the same university-affiliated early-stage companies (including Alcinous, MindImmune, Lenoss), with shared Managing Director Thorne Sparkman, making it the most directly comparable peer.
• Osage University Partners: A venture capital firm that invests exclusively in startup companies commercializing technologies out of university research. Highly analogous to RightHill in sourcing IP directly from research institutions and leading seed rounds, though operating at a larger national scale.
• The Engine (MIT): Venture fund spun out of MIT to commercialize Tough Tech from the university's research base. Directly comparable as a university-anchored early-stage investor that builds syndicates and supports founders through lab-to-market milestones.
• University of Chicago Ventures: The investment arm of the University of Chicago that builds and funds startups from UChicago research. Operates the same university-spinout thesis as RightHill and serves as a useful benchmark for how an affiliated VC scales from a single research institution.
• Brown Angel Group: Brown University-affiliated angel investor network listed as a RightHill ecosystem partner. Highly relevant given shared LP pool, shared deal sourcing from Brown founders, and complementary check sizes for university-originated seed rounds.

Broad incumbents

• Allied Minds: Public company that forms, funds, and commercializes startup businesses based on IP from US federal labs and research universities. Comparable activity (university IP commercialization) but operates at much larger scale and across multiple institutions.

Emerging players

• Breakout Ventures: Early-stage venture firm that funds science-driven founders commercializing research breakthroughs. Similar university-research lab-to-market orientation and seed-stage ticket size, though not affiliated with a single institution.

Regional players

• Hatteras Venture Partners: Durham, NC-based early-stage venture firm investing in life sciences and technology from regional research institutions. Comparable in regional research-anchored thesis and seed-stage activity, though based in a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RightHill Ventures